Revenue Growth: 26% year-over-year increase to $292 million. Adjusted EBITDA Improvement: Improved by nearly $10 million year-over-year. Revenue to CAC Ratio: 4.6x. SelectRx Membership: Over 86,000, ...
Source LinkRevenue Growth: 26% year-over-year increase to $292 million. Adjusted EBITDA Improvement: Improved by nearly $10 million year-over-year. Revenue to CAC Ratio: 4.6x. SelectRx Membership: Over 86,000, ...
Source Link
Comments